Increased nuchal translucency in children with congenital heart defects and normal karyotype—is there a correlation with mortality?

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Increased nuchal translucency in children with congenital heart defects and normal karyotype—is there a correlation with mortality? / Kristensen, Rasmus; Omann, Camilla; Gaynor, J. William; Rode, Line; Ekelund, Charlotte K.; Hjortdal, Vibeke E.

In: Frontiers in Pediatrics, Vol. 11, 1104179, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kristensen, R, Omann, C, Gaynor, JW, Rode, L, Ekelund, CK & Hjortdal, VE 2023, 'Increased nuchal translucency in children with congenital heart defects and normal karyotype—is there a correlation with mortality?', Frontiers in Pediatrics, vol. 11, 1104179. https://doi.org/10.3389/fped.2023.1104179

APA

Kristensen, R., Omann, C., Gaynor, J. W., Rode, L., Ekelund, C. K., & Hjortdal, V. E. (2023). Increased nuchal translucency in children with congenital heart defects and normal karyotype—is there a correlation with mortality? Frontiers in Pediatrics, 11, [1104179]. https://doi.org/10.3389/fped.2023.1104179

Vancouver

Kristensen R, Omann C, Gaynor JW, Rode L, Ekelund CK, Hjortdal VE. Increased nuchal translucency in children with congenital heart defects and normal karyotype—is there a correlation with mortality? Frontiers in Pediatrics. 2023;11. 1104179. https://doi.org/10.3389/fped.2023.1104179

Author

Kristensen, Rasmus ; Omann, Camilla ; Gaynor, J. William ; Rode, Line ; Ekelund, Charlotte K. ; Hjortdal, Vibeke E. / Increased nuchal translucency in children with congenital heart defects and normal karyotype—is there a correlation with mortality?. In: Frontiers in Pediatrics. 2023 ; Vol. 11.

Bibtex

@article{210e4a85f59145e5ada62c22025c57cc,
title = "Increased nuchal translucency in children with congenital heart defects and normal karyotype—is there a correlation with mortality?",
abstract = "Objectives: Our objective was to investigate if an increased nuchal translucency (NT) was associated with higher mortality in chromosomally normal children with congenital heart defects (CHD). Methods: In a nationwide cohort using population-based registers, we identified 5,633 liveborn children in Denmark with a pre- or postnatal diagnosis of CHD from 2008 to 2018 (incidence of CHD 0.7%). Children with chromosomal abnormalities and non-singletons were excluded. The final cohort compromised 4,469 children. An increased NT was defined as NT > 95th-centile. Children with a NT > 95th-centile vs. NT < 95th-centile including subgroups of simple- and complex CHD were compared. Mortality was defined as death from natural causes, and mortalities were compared among groups. Survival analysis with Cox-regression was used to compare rates of mortality. Analyses were adjusted for mediators (possibly explanatory factors between increased NT and higher mortality): preeclampsia, preterm birth and small for gestational age. And for confounding effects of extracardiac anomalies and cardiac intervention, due to their close association to both the exposure and the outcome (i.e., confounders). Results: Of the 4,469 children with CHD, 754 (17%) had complex CHD and 3,715 (83%) simple CHD. In the combined group of CHDs the mortality rate was not increased when comparing those with a NT > 95th-centile to those with a NT < 95th-centile [Hazard ratio (HR) 1.6, 95%CI 0.8;3.4, p = 0.2]. In simple CHD there was a significantly higher mortality rate with a HR of 3.2 (95%CI: 1.1;9.2, p = 0.03) when having a NT > 95th centile. Complex CHD had no differences in mortality rate between a NT > 95th-centile and NT < 95th-centile (HR 1.1, 95%CI: 0.4;3.2, p = 0.8). All analysis adjusted for severity of CHD, cardiac operation and extracardiac anomalies. Due to limited numbers the association to mortality for a NT > 99th centile (>3.5 mm) could not be assessed. Adjustment for mediating (preeclampsia, preterm birth, small for gestational age) and confounding variables (extracardiac anomalies, cardiac intervention) did not alter the associations significantly, except for extracardiac anomalies in simple CHD. Conclusion: An increased NT > 95th-centile is correlated with higher mortality in children with simple CHD, but the underlying cause is unknown and undetected abnormal genetics might explain the correlation rather than the increased NT itself, hence further research is warranted.",
keywords = "congenital heart defects, fetal medicine, mortality, nuchal translucency, prenatal screening, ultrasound",
author = "Rasmus Kristensen and Camilla Omann and Gaynor, {J. William} and Line Rode and Ekelund, {Charlotte K.} and Hjortdal, {Vibeke E.}",
note = "Publisher Copyright: 2023 Kristensen, Omann, Gaynor, Rode, Ekelund and Hjortdal.",
year = "2023",
doi = "10.3389/fped.2023.1104179",
language = "English",
volume = "11",
journal = "Frontiers in Pediatrics",
issn = "2296-2360",
publisher = "Frontiers Media",

}

RIS

TY - JOUR

T1 - Increased nuchal translucency in children with congenital heart defects and normal karyotype—is there a correlation with mortality?

AU - Kristensen, Rasmus

AU - Omann, Camilla

AU - Gaynor, J. William

AU - Rode, Line

AU - Ekelund, Charlotte K.

AU - Hjortdal, Vibeke E.

N1 - Publisher Copyright: 2023 Kristensen, Omann, Gaynor, Rode, Ekelund and Hjortdal.

PY - 2023

Y1 - 2023

N2 - Objectives: Our objective was to investigate if an increased nuchal translucency (NT) was associated with higher mortality in chromosomally normal children with congenital heart defects (CHD). Methods: In a nationwide cohort using population-based registers, we identified 5,633 liveborn children in Denmark with a pre- or postnatal diagnosis of CHD from 2008 to 2018 (incidence of CHD 0.7%). Children with chromosomal abnormalities and non-singletons were excluded. The final cohort compromised 4,469 children. An increased NT was defined as NT > 95th-centile. Children with a NT > 95th-centile vs. NT < 95th-centile including subgroups of simple- and complex CHD were compared. Mortality was defined as death from natural causes, and mortalities were compared among groups. Survival analysis with Cox-regression was used to compare rates of mortality. Analyses were adjusted for mediators (possibly explanatory factors between increased NT and higher mortality): preeclampsia, preterm birth and small for gestational age. And for confounding effects of extracardiac anomalies and cardiac intervention, due to their close association to both the exposure and the outcome (i.e., confounders). Results: Of the 4,469 children with CHD, 754 (17%) had complex CHD and 3,715 (83%) simple CHD. In the combined group of CHDs the mortality rate was not increased when comparing those with a NT > 95th-centile to those with a NT < 95th-centile [Hazard ratio (HR) 1.6, 95%CI 0.8;3.4, p = 0.2]. In simple CHD there was a significantly higher mortality rate with a HR of 3.2 (95%CI: 1.1;9.2, p = 0.03) when having a NT > 95th centile. Complex CHD had no differences in mortality rate between a NT > 95th-centile and NT < 95th-centile (HR 1.1, 95%CI: 0.4;3.2, p = 0.8). All analysis adjusted for severity of CHD, cardiac operation and extracardiac anomalies. Due to limited numbers the association to mortality for a NT > 99th centile (>3.5 mm) could not be assessed. Adjustment for mediating (preeclampsia, preterm birth, small for gestational age) and confounding variables (extracardiac anomalies, cardiac intervention) did not alter the associations significantly, except for extracardiac anomalies in simple CHD. Conclusion: An increased NT > 95th-centile is correlated with higher mortality in children with simple CHD, but the underlying cause is unknown and undetected abnormal genetics might explain the correlation rather than the increased NT itself, hence further research is warranted.

AB - Objectives: Our objective was to investigate if an increased nuchal translucency (NT) was associated with higher mortality in chromosomally normal children with congenital heart defects (CHD). Methods: In a nationwide cohort using population-based registers, we identified 5,633 liveborn children in Denmark with a pre- or postnatal diagnosis of CHD from 2008 to 2018 (incidence of CHD 0.7%). Children with chromosomal abnormalities and non-singletons were excluded. The final cohort compromised 4,469 children. An increased NT was defined as NT > 95th-centile. Children with a NT > 95th-centile vs. NT < 95th-centile including subgroups of simple- and complex CHD were compared. Mortality was defined as death from natural causes, and mortalities were compared among groups. Survival analysis with Cox-regression was used to compare rates of mortality. Analyses were adjusted for mediators (possibly explanatory factors between increased NT and higher mortality): preeclampsia, preterm birth and small for gestational age. And for confounding effects of extracardiac anomalies and cardiac intervention, due to their close association to both the exposure and the outcome (i.e., confounders). Results: Of the 4,469 children with CHD, 754 (17%) had complex CHD and 3,715 (83%) simple CHD. In the combined group of CHDs the mortality rate was not increased when comparing those with a NT > 95th-centile to those with a NT < 95th-centile [Hazard ratio (HR) 1.6, 95%CI 0.8;3.4, p = 0.2]. In simple CHD there was a significantly higher mortality rate with a HR of 3.2 (95%CI: 1.1;9.2, p = 0.03) when having a NT > 95th centile. Complex CHD had no differences in mortality rate between a NT > 95th-centile and NT < 95th-centile (HR 1.1, 95%CI: 0.4;3.2, p = 0.8). All analysis adjusted for severity of CHD, cardiac operation and extracardiac anomalies. Due to limited numbers the association to mortality for a NT > 99th centile (>3.5 mm) could not be assessed. Adjustment for mediating (preeclampsia, preterm birth, small for gestational age) and confounding variables (extracardiac anomalies, cardiac intervention) did not alter the associations significantly, except for extracardiac anomalies in simple CHD. Conclusion: An increased NT > 95th-centile is correlated with higher mortality in children with simple CHD, but the underlying cause is unknown and undetected abnormal genetics might explain the correlation rather than the increased NT itself, hence further research is warranted.

KW - congenital heart defects

KW - fetal medicine

KW - mortality

KW - nuchal translucency

KW - prenatal screening

KW - ultrasound

UR - http://www.scopus.com/inward/record.url?scp=85149647007&partnerID=8YFLogxK

U2 - 10.3389/fped.2023.1104179

DO - 10.3389/fped.2023.1104179

M3 - Journal article

C2 - 36873643

AN - SCOPUS:85149647007

VL - 11

JO - Frontiers in Pediatrics

JF - Frontiers in Pediatrics

SN - 2296-2360

M1 - 1104179

ER -

ID: 365811758